PM360

DECEMBER 14, 2023

Build a strong professional network by connecting with colleagues, mentors, and industry peers. Networking can provide valuable insights, advice, and opportunities. Career paths often have setbacks and challenges, but persistence can lead to success. Identify the skills and knowledge you need to succeed in your chosen field.

Networking 52

Networking Management Education Training 52

Clarivate

MAY 14, 2024

While initially developed to help regulate blood sugar levels, they have also been found to promote appetite suppression, leading to weight loss in patients. What’s leading to the boom in development of semaglutide biosimilars? Per recent Clarivate estimates, the therapeutic market for these drugs is valued at approximately $1.7

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

European Pharmaceutical Review

APRIL 2, 2024

in the monographs for Water for Injection (0169) and Purified Water (0008) on 1 April 2024. on 1 January 2024. She is the Global Lead for the rFC implementation project and is an active contributor to the Analytical Technology Centers within Roche’s Global QC network. did in Europe with rFC four years ago.

Ethics 86

Ethics Manufacturing Marketing Networking 86

Spotio

NOVEMBER 20, 2023

The best distributors have spent years building their networks, which means they can get your products on retail shelves quicker and more consistently than you could on your own. Making them will build trust that could lead to long-term partnerships. Second, it will keep leads from falling through the cracks.

Retail 52

Retail Distribution Sales Manufacturing 52

Clarivate

SEPTEMBER 18, 2023

Many of the world’s leading scientometric and science policy researchers gather annually at the STI conference, making it the ideal venue to connect the current work of ISI with the legacy of Dr. Garfield and his indelible impact on the scholarly community.

Specialization 119

Specialization Networking Leads Professional Services 119

PM360

DECEMBER 17, 2023

Publicis Groupe announced the appointment of Stephen Farquhar as Chief Executive Officer of Publicis Health, effective February 1, 2024. In his new role, Farquhar will be responsible for leading Publicis Health businesses in the U.S., In his new role, Farquhar will be responsible for leading Publicis Health businesses in the U.S.,

Media 52

Media Healthcare Healthcare Leads 52

Pharmaceutical Technology

JUNE 21, 2023

PharmaTher plans to file an abbreviated new drug application with the FDA for Ketarx in July 2023, and to secure approval in the first quarter of 2024. It is being given in hospitals and clinics for the treatment of mental health, neurological and pain disorders outside the FDA-approved indications.

Distribution 52

Distribution FDA Specialization Sales 52

Legacy MEDSearch

SEPTEMBER 13, 2023

Food and Drug Administration (FDA) via the 510(k) pathway, with potential clearance expected during the first half of 2024. Legacy systems for breathing assistance are causing multiple complications leading to physical damage, infection and possible death.

FDA 52

FDA Food and Drug Administration Recruitment Medical 52

PM360

DECEMBER 20, 2023

Learn more about why each company went with its respective strategy and the current outlook for each company in 2024 and beyond. The deal is expected to close in 2024. What is your outlook for 2024 and how do you believe companies can effectively differentiate themselves? and 10X Capital Venture Acquisition Corp.

Management 109

Management Marketing Healthcare Healthcare 109

Pharma Marketing Network

NOVEMBER 23, 2021

The November 11 th ACE Awards celebrated Merck’s Women’s Network and Otsuka’s Network of Otsuka’s Women (NOW) for their exceptional initiatives that are driving impactful progress for women in the workforce. Merck’s Women’s Network. When it was first formed in 1995, the Women’s Network started with 200 members across 3 chapters.

Networking 52

Networking Healthcare Healthcare Specialization 52

Legacy MEDSearch

MAY 26, 2023

From 2024, Biosency will make its BVS 3 technology available to healthcare professionals for integration into the BORA Care® digital medical device, with the aim of obtaining reimbursement as part of an advance payment scheme. Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. It resulted in 3.23

Medical 52

Medical Recruitment Management Patients 52

Clarivate

DECEMBER 6, 2022

healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. The IDN also plans to open a proton beam therapy center by 2024, which will be the first in Wisconsin.

Networking 52

Networking Healthcare Healthcare Competition 52

European Pharmaceutical Review

JULY 21, 2023

Recent guidance published by the European Medicines Agency outlines measures that will be taken to increase preparedness for the autumn/winter 2023-2024. Yammahi was instrumental in building Hayat’s extensive distribution network needed to supply vaccines during the COVID-19 pandemic.

Pharmaceutical 93

Pharmaceutical Food and Drug Administration Transportation Manufacturing 93

Clarify Health

APRIL 18, 2024

ASC market size is projected to grow to more than $75 billion by 2030 and in January 2024, CMS announced the addition of 41 new billing codes for covered procedures for ASCs. For example, a managed care team can identify underserved areas within their market and strategically expand their network by acquiring or merging with existing ASCs.

Marketing 52

Marketing Competition Physicians Management 52

Legacy MEDSearch

AUGUST 21, 2023

Muratoglu invented the first crosslinked polyethylene, and the first of multiple generations of vitamin E, antioxidant polyethylene for leading orthopaedic companies. “We Global expansion will begin in 2024. This new generation polyethylene is the latest, first-of-a-kind innovation by Orhun Muratoglu, Ph.D.,

Food and Drug Administration 52

Food and Drug Administration FDA Recruitment Marketing 52

Legacy MEDSearch

AUGUST 17, 2023

This enhanced functionality will be made available commercially in 2024. The receipt of our 10 th 510(k) clearance is another milestone demonstrating Welldoc’s commitment to leading innovation in digital health. Our clients include both blue-chip companies and innovative startups within the MedTech space.

FDA 52

FDA Food and Drug Administration Recruitment Management 52

pharmaphorum

JANUARY 24, 2023

Energy crisis effects will be felt across healthcare, but for medicines manufacturing and delivery the issue is especially complex because the networks of medicine supply extend across the globe and across countries which see differing impacts of energy costs and supply. Medicines manufacturing is energy intensive.

Medicine 95

Medicine Healthcare Healthcare Pharma 95

Legacy MEDSearch

JUNE 14, 2023

Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, announced it has received U.S. Surmodics is a leading provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. Surmodics, Inc.

FDA 52

FDA Food and Drug Administration Recruitment Medical 52

Clarivate

DECEMBER 19, 2022

The plans are profitable and continue to draw new Medicare enrollees, leading all top payers to make investments in retaining and attracting enrollees. Expansion opportunities for 2024 are relatively obvious, since the partners could expand to the three states with Walmart Health locations (Arkansas, Illinois, Texas ).

Competition 52

Competition Retail Insurance Marketing 52

PM360

MARCH 22, 2024

Due to the low prevalence of RD and the international scope of most PAGs, challenges arise from language translation and differences in international policies, leading to issues such as limited public awareness and insufficient engagement with patients and healthcare professionals 3. Another major hurdle for the PAGs is funding.

Patients 52

Patients Recruitment Ethics Government 52

PM360

OCTOBER 13, 2023

network embraced an ad-supported subscription option. The insights available from CTV campaigns can lead to more informed planning, real-time optimization, higher return on advertising spend (ROAS), and ultimately stronger business outcomes. Last year was historic for the television industry. Why, you ask? consumers subscribe to.

Media 64

Media Marketing Networking Retail 64

Legacy MEDSearch

MAY 9, 2023

They developed the Virtuoso Surgical system with a design team helmed by COO and Lead Engineer Richard Hendrick, PhD. Company executives anticipate regulatory submission in 2024, pursuant of FDA approval for sale in the United States. physicians,” Robert J.

Recruitment 52

Recruitment Engineering Sales Medical 52

PM360

APRIL 22, 2024

Continuing to increase frequency in multi- channel messaging with less effectiveness can lead to a data deluge. This will lead to better rates of adoption, behavior change, and onward action. Such platforms attempt to make learning more enjoyable and motivate competition, hopefully leading to better retention of knowledge and skills.

Education 59

Education Physicians Healthcare Healthcare 59

European Pharmaceutical Review

JUNE 27, 2023

Our lead candidate MaaT013, a donor-derived, standardised, high-richness, high-diversity MET is currently being evaluated in a Phase III trial (ARES) in Europe and in an Early Access Program in Europe, mostly in acute Graft-versus Host Disease (aGvHD), a severe complication following stem cell transplantation.

Food and Drug Administration 96

Food and Drug Administration Manufacturing Medicine Pharma 96

Clarivate

MAY 13, 2024

According to Clarivate’s latest enrollment data, as of January 2024, Medicaid enrollment had plummeted by nearly 9 million compared to six months prior. For 2024, 18% of enrollees were new to exchange coverage, according to the Centers for Medicare and Medicaid Services. million between January 2023 and January 2024. to about 2.5

Insurance 52

Insurance Marketing Healthcare Healthcare 52

European Pharmaceutical Review

APRIL 25, 2024

Four key barriers to female career progression were explored during a panel at the UK 2024 Advanced Therapies conference in March. While women are “spread thinly” in the cell and gene sector, she shared that there is still a “great network” of professionals in this demographic. Internet] BioProcess International. cited 2024Apr].

Networking 86

Networking Recruitment Management Leads 86

European Pharmaceutical Review

FEBRUARY 9, 2024

Under the terms of the agreement, BioNTech will pay $50 million to Autolus, granting the immunotherapy company rights including the option to access Autolus’ commercial and clinical site network, manufacturing capacities in the UK and commercial supply infrastructure.

Networking 99

Networking Manufacturing Sales Leads 99

Star OUTiCO

SEPTEMBER 21, 2023

Pharma can capitalise on the remainder of the year and prep for 2024 by deploying innovative brand tactics now. Nick : I’m Nick, Head of Consulting, and I’m a specialist in digital health, data performance and customer experience, leading the very talented team of next generation analysts. Mark : Exactly.

Pharma 52

Pharma Sales Recruitment Engineering 52

Legacy MEDSearch

DECEMBER 19, 2022

” Added Ferrera, “We are confident that use of the BossStent® device will provide an on-label solution for symptomatic cerebral venous diseases leading to papilledema, pulsatile tinnitus and IIH. Over time, we believe use of the device will become the standard of care.” Press Release by: Sonorous NV.

Patients 98

Patients Recruitment Physicians Management 98

European Pharmaceutical Review

NOVEMBER 8, 2022

Sandoz , a leading antibiotics producer has announced its €50 million investment to increase Europe’s manufacturing capacity of finished dosage form (FDF) penicillin, the most common form of antibiotic worldwide, to enhance global manufacturing capacity of amoxicillin and other major penicillin products.

Manufacturing 52

Manufacturing Networking Pharmaceutical Medicine 52

Evolve Your Success

AUGUST 22, 2023

But Mignon’s journey is not only about sales; it’s a testament to the power of networking and community engagement. That’s how leads can come to me. Is that how you get the majority of your leads, or are you out there hunting for leads as well? Can you put me in contact with the rep for that?” It started there.

Sales 52

Sales Medical sales Networking Medical 52

PM360

MARCH 22, 2024

Those involved are Trina Stonner, RN, MSN, Avant’s Chief Customer Officer and President, co-leading Real Chemistry’s Medical group with Suzanne Jacobs, who leads Real Chemistry’s current medical team and is based in London. The UK-based contingent now joins the Network in North America, sitting within the Havas New York Village.

Media 52

Media Recruitment Education Medical 52

Evolve Your Success

JANUARY 10, 2024

One thing that is not talked about enough, and I’m going to have some guests on here in 2024, is that there are a lot of people who get into this space and then quit 5 or 6 months in. Your network is your net worth. I also have a lead vest on. It’s double-sided. This is an issue. How do you do all that stuff?

Sales 52

Sales Medical Medical sales Doctors 52

Pharmaceutical Technology

JANUARY 16, 2023

Negotiations over these products are expected from October 2023 and run until August 2024. The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets. An improved global environment for drug price increases may materialize from Q3. Free Report.

Pharma 64

Pharma Manufacturing Pharmaceutical Marketing 64

Pharmaceutical Technology

JANUARY 16, 2023

Negotiations over these products are expected from October 2023 and run until August 2024. The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets. An improved global environment for drug price increases may materialize from Q3. Free Report.

Pharma 52

Pharma Manufacturing Pharmaceutical Marketing 52

Pharmaceutical Technology

JUNE 20, 2023

GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019 [i]. Neural networks learn to “translate” from language A to language B. This additional feedback also leads to improvements to the NMT, to ensure it achieves continuous high-quality translations.

Electronics 52

Electronics Medical Healthcare Healthcare 52

Clarivate

DECEMBER 14, 2023

Pharmaceutical benefit managers, M&A activity among integrated delivery networks, disruption by nontraditional healthcare entities, enrollment, and the 2024 presidential election are five areas to pay attention to moving into 2024. Clarivate experts explain why these topics are ones to watch in 2024.

Marketing 52

Marketing Healthcare Healthcare Insurance 52